- 01 Jun 2020
- Working Paper Summaries
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
Retail pharmacy data illustrates it can be misleading to use list prices instead of net prices to understand pharmaceutical prices. Analysts and economists working in public policy should be extremely cautious in drawing policy conclusions based on list prices alone.
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus pandemic might lead to major changes in patient care, physician compensation, and regulation. Experts from Harvard Business School's Health Care Initiative share their predictions. Open for comment; Comment(s) posted.
- 09 Jan 2018
- Working Paper Summaries
Identifying Sources of Inefficiency in Health Care
This economic study finds evidence of allocative inefficiency and substantial variation in comparative advantage across hospitals, with the benefits from treatment being much higher in some hospitals than others. The study overall suggests new directions for research on productivity in healthcare.
What Can Economics Say About Alzheimer's Disease?
This essay discusses the role of market frictions and "missing medicines" in drug innovation and highlights how frameworks and toolkits of economists can help our understanding of the determinants and effects of Alzheimer's disease on health.